An Activist’s Guide to Tuberculosis Drugs 2016 Update
The guide provides a brief summary of safety and efficacy data for the drugs currently in use for TB, and suggests advocacy points for activists.
Since An Activist’s Guide to Tuberculosis Drugs was first published in 2014, updated guidelines, new findings, and other factors have shifted the research and access priorities for several TB drugs. Still, more research is needed to ensure that TB treatment becomes shorter, simpler, less toxic, and more tolerable, and affordable. Activists can contribute to the development and uptake of improved TB treatment by calling attention to research and access priorities. This guide provides a brief summary of safety and efficacy data for those drugs currently in use for TB (some of which have been approved for other diseases but are used off-label for TB), and suggests advocacy points for activists.
To access the guide, click here.
Source: Treatment Action Group
